Lpl Financial LLC Lexicon Pharmaceuticals, Inc. Transaction History

Lpl Financial LLC

$218 Billion
Q3 2024

A detailed history of Lpl Financial LLC transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Lpl Financial LLC holds 63,035 shares of LXRX stock, worth $47,906. This represents 0.0% of its overall portfolio holdings.

Number of Shares

63,035

Previous 61,085 3.19%

Holding current value

$47,906

Previous $102,000 3.92%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$1.51 - $2.39 $2,944 - $4,660	1,950 Added 3.19%	63,035 $98,000
Q2 2024 Aug 07, 2024	SELL	$1.54 - $2.28 $44,472 - $65,841	-28,878 Reduced 32.1%	61,085 $102,000
Q1 2024 May 10, 2024	BUY	$1.3 - $3.58 $59,759 - $164,569	45,969 Added 104.49%	89,963 $215,000
Q4 2023 Feb 14, 2024	BUY	$1.0 - $1.53 $17,000 - $26,010	17,000 Added 62.98%	43,994 $67,000
Q3 2023 Nov 13, 2023	BUY	$1.06 - $2.33 $2,127 - $4,676	2,007 Added 8.03%	26,994 $29,000
Q2 2023 Jul 31, 2023	BUY	$2.15 - $3.49 $9,148 - $14,849	4,255 Added 20.52%	24,987 $57,000
Q4 2022 Feb 07, 2023	BUY	$1.8 - $2.56 $57 - $81	32 Added 0.15%	20,732 $39,000
Q2 2022 Aug 12, 2022	BUY	$1.31 - $2.69 $12,707 - $26,093	9,700 Added 88.18%	20,700 $39,000
Q1 2022 May 16, 2022	BUY	$1.95 - $3.89 $21,450 - $42,790	11,000 New	11,000 $23,000
Q3 2019 Nov 13, 2019	SELL	$1.2 - $6.66 $44,317 - $245,960	-36,931 Closed	0 $0
Q2 2019 Aug 09, 2019	SELL	$5.35 - $7.11 $2,493 - $3,313	-466 Reduced 1.25%	36,931 $232,000
Q1 2019 May 08, 2019	BUY	$4.36 - $7.94 $31,112 - $56,659	7,136 Added 23.58%	37,397 $208,000
Q4 2018 Feb 07, 2019	SELL	$6.15 - $10.51 $20,657 - $35,303	-3,359 Reduced 9.99%	30,261 $201,000
Q3 2018 Nov 14, 2018	BUY	$10.32 - $13.06 $3,870 - $4,897	375 Added 1.13%	33,620 $359,000
Q2 2018 Aug 14, 2018	BUY	$7.8 - $13.69 $31,769 - $55,759	4,073 Added 13.96%	33,245 $399,000
Q1 2018 May 15, 2018	BUY	$7.86 - $11.39 $58,368 - $84,582	7,426 Added 34.15%	29,172 $250,000
Q4 2017 Feb 14, 2018	SELL	$8.77 - $12.28 $56,776 - $79,500	-6,474 Reduced 22.94%	21,746 $215,000
Q3 2017 Nov 14, 2017	BUY	$12.17 - $16.3 $47,536 - $63,667	3,906 Added 16.06%	28,220 $347,000
Q2 2017 Aug 14, 2017	BUY	N/A	24,314	24,314 $400,000

Others Institutions Holding LXRX

# of Institutions

141

Shares Held

238M

Call Options Held

459K

Put Options Held

133K

View Full List

About LEXICON PHARMACEUTICALS, INC.

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $143M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

More about LXRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.

Account

Lpl Financial LLC Lexicon Pharmaceuticals, Inc. Transaction History